Filing Details
- Accession Number:
- 0001553878-14-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-23 16:23:57
- Reporting Period:
- 2014-05-21
- Filing Date:
- 2014-05-23
- Accepted Time:
- 2014-05-23 16:23:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1178670 | Alnylam Pharmaceuticals Inc. | ALNY | Pharmaceutical Preparations (2834) | 770602661 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1219015 | K John Clarke | C/O Cardinal Health Partners 230 Nassau Street Princeton NJ 08542 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-05-21 | 10,000 | $7.08 | 10,000 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2014-05-21 | 10,000 | $14.74 | 20,000 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2014-05-21 | 15,000 | $15.91 | 35,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-05-21 | 22,792 | $52.95 | 12,208 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-05-21 | 2,500 | $54.21 | 9,708 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-05-21 | 6,908 | $55.47 | 2,800 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-05-21 | 2,800 | $56.19 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2014-05-21 | 10,000 | $0.00 | 10,000 | $7.08 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2014-05-21 | 10,000 | $0.00 | 10,000 | $14.74 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2014-05-21 | 15,000 | $0.00 | 15,000 | $15.91 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2006-06-08 | 2015-06-08 | No | 4 | M | Direct |
0 | 2007-06-01 | 2016-06-01 | No | 4 | M | Direct |
0 | 2008-06-01 | 2017-06-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 8,891 | Indirect | By Managed Account |
Footnotes
- The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2014.
- Sale prices ranged from from $52.50 to $53.48.
- Sale prices ranged from from $53.87 to $54.50.
- Sale prices ranged from from $54.94 to $55.92.
- Sale prices ranged from from $55.94 to $56.62.
- These shares are owned by CHP II, L.P. The reporting person is the Managing General Partner of CHP II Management LLC, the General Partner of CHP II L.P. The reporting person may be deemed to beneficially own the shares held by CHP II, L.P. although he disclaims beneficial ownership except to the extent of his proportionate pecuniary interest therein.